Navigation Links
Dana-Farber: Study reports first success of targeted therapy in type of non-small cell lung cancer
Date:5/31/2012

BOSTONA novel compound has become the first targeted therapy to benefit patients with the most common genetic subtype of lung cancer, an international clinical trial led by scientists at Dana-Farber Cancer Institute and other institutions will report at the annual meeting of the American Society of Clinical Oncology (ASCO) June 1-5 in Chicago.

Pasi A. Jnne, MD, PhD, scientific co-director of Dana-Farber's Belfer Institute for Applied Cancer Science, will present the findings from the randomized phase II study (abstract 7503) on Monday, June 4, 3 p.m. CT, E Hall D2, McCormick Place.

The study involved 87 non-small cell lung cancer (NSCLC) patients whose tumors carry a mutation in the gene KRAS. Such tumors account for about 20 percent of NSCLC cases, but no targeted therapy has proved effective against them in previous clinical research. The drug under investigation, selumetinib, doesn't attack KRAS directly, but interferes with one of its molecular henchmen, a protein called MEK.

Participants in the study all had advanced stages of the disease. They received the standard chemotherapy agent docetaxel in combination with either selumetinib or a placebo.

By many measures the rate and duration of response to treatment, change in tumor size, and proportion of patients alive and showing no signs of advancing disease -- the group receiving selumetinib did significantly better than the other group. Most clinically significant were the improved rate of response to treatment (37 percent compared to 0 percent in the placebo arm) and prolonged progression-free survival (5.3 months compared to 2.1 months in the placebo arm). Although patients in the selumetinib group survived longer, on average, than those in the placebo group 9.4 months compared to 5.2 months the improvement was not considered statistically significant.

"This clinical trial demonstrates that a combination of chemotherapy and selumetinib is significantly
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Humans Can Sniff Out Old Age in Others, Study Shows
2. Infant Smarts Similar With Different Types of Formula: Study
3. Pre-op Treatments Boost Survival for Esophageal Cancer Patients: Study
4. Cooling Helps Oxygen-Deprived Newborns: Study
5. Immigrant women giving birth in Spain suffer great stress, a study warns
6. Once-Obese Women Still Face Stigma, Study Finds
7. Surly People Tend to Like Fierce Dogs, Study Shows
8. Nordic Walking a Winner for Heart Failure Patients, Study Says
9. Common Painkillers May Help Prevent Skin Cancer: Study
10. Antioxidant shows promise as treatment for certain features of autism, Stanford study finds
11. Tight Blood-Sugar Control Shows Mixed Results for Health of Kidneys: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... @the_USO & @SesameStreet are proud to kick-off ... the next 6 months! , Today, the ... together to show their heartfelt thanks to those who currently serve ... distribution to our servicemen and women. The group was also ... the USO as well as the success of the Sesame ...
(Date:5/22/2013)... 22, 2013 Nearly 50,000 veterans appeals ... in fiscal year 2012, with even more—54,033—expected by fiscal ... for a decision as the agency reports reduced decisions ... veterans disability appeal services. The BVA is ... , Although the BVA received 49,611 cases in FY ...
(Date:5/22/2013)... By Dennis Thompson HealthDay Reporter , , WEDNESDAY, ... migraines or back pain are more likely to attempt ... or another psychiatric condition, according to a new study. ... conditions should be aware they are at increased risk ... Veterans Affairs Serious Mental Illness Treatment Resource and Evaluation ...
(Date:5/22/2013)... Bodybuilding.com is giving back to ... 2013) Bodybuilding.com will be donating $1 from EVERY purchase made ... “We are extremely grateful for the men and women who ... DeLuca, CEO and founder of Bodybuilding.com. “It’s an honor to ... much. Hire Heroes USA is an amazing organization that supports ...
(Date:5/22/2013)... Today, Zane Benefits, Inc. published a new ... Zane Benefits, which provides comprehensive and flexible alternatives to ... defined contribution plans and health reimbursement ... in 2014 as part of the Affordable Care Act ... will become available through new state health insurance exchanges. ...
Breaking Medicine News(10 mins):Health News:The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC 2Health News:The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC 3Health News:The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC 4Health News:The USO and Sesame Street Announce Spring Kick Off of World Tour at Biannual Care Package Service Project Event in DC 5Health News:Veterans Disability Appeals See Fewer Decisions in FY2012, Reports Allsup 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 2Health News:Migraine, Chronic Back Pain Tied to Higher Suicide Risk 3Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3
... of Medical Records Into a User,s ... ... UNIVAL, Inc., a healthcare,company that delivers a variety of integrated ... the Microsoft,HealthVault platform. HealthVault lets consumers collect, store, and share,health ...
... A new video blog will document one woman,s fight to end the ... participants of The Diabetes Challenge, a contest hosted by the Lifestyle Center ... ... -- A new video blog will document one woman,s fight to end ...
... Breast Cancer Awareness Month. And, there,s no better time than the present ... to become more informed about how the disease could affect you, your ... ... October 23, 2008 -- Last year, over 2.3 million women were diagnosed ...
... 22 Every year in Jacksonville,nearly 600 adults ... now,their long road to recovery lacked long-term support. ... the only program,in Florida created to help people ... community reintegration., The Brain Injury Association of ...
... physician, caregiver and pet therapy awards, MILWAUKEE, ... a,top national award from the Planetree organization. Aurora ... for Kradwell School at,Planetree,s national conference in Chicago ... dedicated to a,patient-centered, holistic approach to health care. ...
... Verification Safeguards Allow Thieves to Steal, SAN ... Americans,are the victims of identity theft, and in ... theft victim Eric Drew claims that the,credit industry ... by fully automating their identity verification systems, credit,card ...
Cached Medicine News:Health News:UNIVAL(R), Inc. Becomes a Microsoft(R) HealthVault(TM) Application Provider 2Health News:Video Blog Chronicles One Woman's Fight Against Her Diabetes 2Health News:The Pink Ribbon That Could Save Your Life 2Health News:The Pink Ribbon That Could Save Your Life 3Health News:Brooks Rehabilitation Opens First Work-Based Brain Injury Rehab Program in Florida 2Health News:Aurora Health Care's Kradwell School Receives National Planetree Award 2Health News:Aurora Health Care's Kradwell School Receives National Planetree Award 3Health News:Aurora Health Care's Kradwell School Receives National Planetree Award 4Health News:Aurora Health Care's Kradwell School Receives National Planetree Award 5Health News:Credit Card Companies Accomplices in Millions of Identity Theft Cases Alleges Eric Drew 2
(Date:5/22/2013)... , May 22, 2013  Avanir Pharmaceuticals, Inc. (NASDAQ: ... an overview of the company at the following conferences. ... , Presentation date: Wednesday May 29, 2013 , Presentation ... Global Healthcare Conference , Presentation date: Wednesday June 5, ... A live webcast and 30-day archive ...
(Date:5/22/2013)... , May 22, 2013  Flagship Ventures, a ... on healthcare and sustainability, today announced the appointment ... a Senior Partner. In this role, Mr. Bancel ... companies. In addition to working closely ... also serves as President and Chief Executive Officer ...
(Date:5/22/2013)... -- Grifols, a global healthcare company based in ... demonstrating that a higher dose of PROLASTIN © -C ... alpha 1 protein in patients with alpha 1 ... the normal range for healthy individuals. AAT deficiency is ... the alpha 1 proteinase inhibitor (A1PI) protein can ...
Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4
... ANN ARBOR, Mich., June 19 ... change interventions with outcomes, announced a,new research ... Insomnia and Overcoming(TM) Depression online behavior,change interventions ... Aetna,s,large employer members. Together, HealthMedia and Aetna ...
... safety and effectiveness of using cloned cells alone ... ... use of a human patient,s cloned infection-fighting T cells as,the sole therapy ... Cassian Yee, M.D., an associate member of the,Clinical Research Division at Fred ...
Cached Medicine Technology:HealthMedia and Aetna to Study Online Insomnia and Depression Interventions 2HealthMedia and Aetna to Study Online Insomnia and Depression Interventions 3HealthMedia and Aetna to Study Online Insomnia and Depression Interventions 4Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation 2Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation 3
... The Acceava Mononucleosis test provides ... Mononucleosis with a simple procedure that ... Side-by-side evaluations with competitive products will ... These attributes enable you to deliver ...
... for the visual, qualitative detection ... infectious mononucleosis in human serum, ... This test is intended as ... of infectious mononucleosis in patients ...
The NOW® Flu B test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results an...
... Absorbable Hemostat is a purified and lyophilized ... a sponge-like pad, is lightly cross-linked, sterile, ... an inherent property of collagen, is largely ... this protein. The helical structure of native ...
Medicine Products: